This is in line with our previous reports indicating that diminished or lost CRFR2 expression in CRC promotes tumor development and aggressiveness, including tumor immunoescape, by regulating molecular circuits involved in sustaining inflammation in the gut [30,36]. This evidence concerns the gene CRHR2 and neoplasm.